Intellia Therapeutics: It May Be Time To Get Excited And Buy (Upgrade)
Source: SeekingAlpha
2025-08-15 12:24:05 ET
Investment Overview
When I last covered Intellia Therapeutics, Inc. ( NTLA ) for Seeking Alpha at the end of May, the share price of the Cambridge, Massachusetts-based pharma company, developing gene therapies using CRISPR technology, was tanking. This was after it reported that a patient with ATTR-CM (transthyretin amyloid cardiomyopathy) being treated with its candidate nexiguran ziclumeran ("nex-z"), had experienced grade 4 liver transaminase elevations....
Read the full article on Seeking Alpha
For further details see:
Intellia Therapeutics: It May Be Time To Get Excited And Buy (Upgrade)
Takeda Pharmaceutical Co Ltd
NASDAQ: TKPHF
TKPHF Trading
0.0% G/L:
$37.83 Last:
113 Volume:
$37.83 Open:
TKPHF Latest News
TKPHF Stock Data
$55,801,616,447
1,559,387,460
N/A
724
N/A
Pharmaceuticals
Healthcare
JP
Chuo-ku
